TNF and lung cancer: We detected higher TNF mRNA levels in PBMCs from patients with lung cancer compared to healthy control subjects (Figure 3F), suggesting enhanced inflammatory activity in the peripheral blood and indicating a systemic immune response associated with lung cancer.